Mobile

A multi-center, double-blind, randomized, parallel group, placebo-controlled 12-week study to investigate glycemic parameters of efficacy, safety/ tolerability and pharmacokinetics of five dose levels...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-001249-24

A multi-center, double-blind, randomized, parallel group, placebo-controlled 12-week study to investigate glycemic parameters of efficacy, safety/ tolerability and pharmacokinetics of five dose levels of RO4998452 in patients with type 2 diabetes mellitus

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• To determine the absolute change in HbA1c concentration from baseline to the end of the treatment period compared to placebo

Critère d'inclusion

  • Type 2 diabetes mellitus

Liens